CTOs on the Move

Frontage Laboratories

www.frontagelab.com

 
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Colon And Rectal Surgery Associates Ltd

Colon And Rectal Surgery Associates Ltd is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Paul, MN. To find more information about Colon And Rectal Surgery Associates Ltd, please visit www.colonrectal.org

Accent Urgent Care and After Hours Pediatrics

Accent Urgent Care and After Hours Pediatrics is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Juniper Partners

Juniper Communities is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Williamstown, NJ. To find more information about Juniper Communities, please visit www.juniperpartners.com

Hansen Medical Inc.

Hansen Medical, Inc. (Hansen Medical) develops, manufactures and sells generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.